Runway Growth Finance (RWAY) Q2 2024 earnings summary

Executive summary

• Completed two new investments totaling $75.5 million in funded loans to Airship Group and ONWARD Medical, focusing on late-stage technology and healthcare sectors.

• Total investment income was $34.2 million and net investment income was $14.6 million for Q2 2024, or $0.37 per share.

• Portfolio consisted of 55 companies as of June 30, 2024, with a fair value of $1.06 billion, 99% in senior secured first lien loans.

• Maintained a disciplined, credit-first approach with a seasoned management team and a diversified portfolio across industries and geographies.

• Two loans, representing 3.1% of the portfolio, were on non-accrual status at quarter-end.

Financial highlights

• Net asset value per share was $13.14 as of June 30, 2024, down from $13.36 at the end of Q1 2024 and $13.50 at year-end 2023.

• Total investment portfolio fair value was $1.06 billion, up 5% sequentially but down 3% year-over-year.

• Operating expenses for Q2 2024 were $19.6 million, down from $22.2 million in Q2 2023.

• Dollar-weighted average annualized yield on the debt portfolio was 15.1% for Q2 2024.

• Net increase in net assets from operations was $8.3 million for Q2 2024.

Outlook and guidance

• Expect $200–$300 million in prepayments in the second half of 2024, including the $75 million CloudPay prepayment.

• Anticipate elevated prepayment-related income for the next few quarters, with plans to redeploy capital and maintain dividend coverage.

• Management expects a strong investment pipeline for the second half of 2024 and remains focused on portfolio performance and diversification.

• Strategic focus remains on late- and growth-stage companies with strong equity sponsorship or insider ownership.

• No expectation of massive Q3 originations; activity likely to be back-end weighted.